Their concerns come in response to the bill unveiled Sunday night by House Republicans that would tighten eligibility rules, ...

Homelessness and HIV share common risk factors, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the ...

Industry leaders and policy experts have said President Trump’s executive order on Most Favored Pricing is flawed and ignores the basic economics of the global drug marketplace.

The House Energy and Commerce Committee has scheduled a public markup hearing for the Republican bill for tomorrow at 2 p.m.

In a press conference, President Donald J. Trump announced that he would sign an executive order that ties drug pricing to ...

Healthcare providers are exploring ways to reduce patient travel through a growing trend of expanding sites of administration ...

A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, ...

Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the ...

Swearing Off Rebates? Payers Say They Are Interested but Not Giving Them Up Just Yet | Asembia AXS25 ...

Swearing Off Rebates? Payers Say They Are Interested but Not Giving Them Up Just Yet | Asembia AXS25 ...

Plan sponsors can choose approach; the PBM has option to move away from rebate-dependent Provide real-time insights that support evidence-based clinical decisions and clear pricing ...

The research is noteworthy given a Supreme Court decision that could result in many dialysis patients switching from commercial insurance plans to Medicare. Private insurance plans reimburse for ...